Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18264245 | 1.00 | FPR2 (0.60) | FPR2FPR1 | |
| SCHEMBL18264283 | 0.88 | FPR2 (0.63) | FPR2FPR1 | |
| SCHEMBL18264285 | 0.88 | FPR2 (0.63) | FPR2FPR1 | |
| SCHEMBL18264220 | 0.83 | FPR2 (0.63) | FPR2FPR1 | |
| SCHEMBL18264221 | 0.83 | FPR2 (0.63) | FPR2FPR1 | |
| SCHEMBL20177478 | 0.83 | FPR2 (0.60) | FPR2FPR1 | |
| SCHEMBL20411634 | 0.83 | FPR2 (0.63) | FPR2FPR1 | |
| SCHEMBL18264291 | 0.82 | FPR2 (0.64) | FPR2FPR1 | |
| SCHEMBL18264289 | 0.82 | FPR2 (0.64) | FPR2FPR1 | |
| SCHEMBL20177795 | 0.81 | FPR2 (0.60) | FPR2FPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331884-B1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KYORIN SEIYAKU KK (JP) | 2020-06-17 | — | — | EP | claimed |
| EP-3331884-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | Kyorin Pharmaceutical Co., Ltd. (JP) | 2018-06-13 | — | — | EP | claimed |
| WO-2016189876-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2016-12-01 | — | — | WO | claimed |
| EP-3331884-B1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KYORIN SEIYAKU KK (JP) | 2020-06-17 | — | — | EP | disclosed |
| EP-3331884-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | Kyorin Pharmaceutical Co., Ltd. (JP) | 2018-06-13 | — | — | EP | disclosed |
| WO-2016189876-A1 | UREA DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2016-12-01 | — | — | WO | disclosed |